This inventor holds 33 USPTO granted patents, plus 5 CIPO patents and 14 EPO patents, primarily in Kinase Inhibitors. Top assignees: Janssen Pharmaceutica Nv, 3-Dimensional Pharmaceuticals, Inc., Dimensional Pharmaceuticals, Inc.. Active years: 2005-2025.
Location History:
- West Chester, PA (US) (2005 - 2011)
- Flourtown, PA (US) (2011 - 2012)
- Lansdale, PA (US) (2014 - 2023)
Company Filing History:
27 out of 2,100 
4 out of 77 
1 out of 2 
Years Active: 2005-2025
Areas of Expertise:
Title: **Kristi A Leonard: Pioneering Innovations in Kinase Inhibition**
Introduction
Kristi A Leonard is a prominent figure in the field of pharmaceutical research, based in West Chester, PA, USA. With an impressive portfolio of 33 patents, Leonard has made significant strides in the development of small molecule inhibitors that target the JAK family of kinases. His contributions have implications for treating various diseases, including inflammatory bowel disease.
Latest Patents
Leonard's latest innovations include two notable patents involving small molecule inhibitors of the JAK family of kinases. The first patent details the compounds known as 2-((1R,4R)-4-(imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)cyclohexyl)acetonitrile, alongside pharmaceutical compositions containing these compounds. These inventions outline methods for producing the compounds and their applications in treating disorders mediated by JAK. His second patent also centers around imidazopyrrolopyridine as inhibitors of the JAK kinases, highlighting similar uses in treating disease states.
Career Highlights
Throughout his career, Leonard has been associated with notable companies including Janssen Pharmaceutica and 3-Dimensional Pharmaceuticals, Inc. His work has played a crucial role in advancing pharmaceutical innovations that have the potential to address significant health challenges.
Collaborations
Leonard's success can also be attributed to his collaborations with talented colleagues such as Aihua Wang and Kevin Douglas Kreutter. These partnerships have fostered a creative environment that has led to breakthrough advancements in kinase inhibition.
Conclusion
As an inventor with a strong focus on therapeutic innovations, Kristi A Leonard continues to contribute significantly to the field of pharmaceuticals. His groundbreaking patents and collaborations underscore the importance of fostering innovation through teamwork and dedication to research. Through his work, Leonard is paving the way for new treatments and improving the lives of those with conditions mediated by JAK kinases.